Rongjun Qian

536 total citations
22 papers, 408 citations indexed

About

Rongjun Qian is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Rongjun Qian has authored 22 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 5 papers in Immunology. Recurrent topics in Rongjun Qian's work include Ferroptosis and cancer prognosis (9 papers), Glioma Diagnosis and Treatment (4 papers) and RNA Interference and Gene Delivery (4 papers). Rongjun Qian is often cited by papers focused on Ferroptosis and cancer prognosis (9 papers), Glioma Diagnosis and Treatment (4 papers) and RNA Interference and Gene Delivery (4 papers). Rongjun Qian collaborates with scholars based in China, Australia and United States. Rongjun Qian's co-authors include Meng Zheng, Bingyang Shi, Fengping Zhu, Tong Jiang, Yan Zou, Weimin Ruan, Jinlong Yin, Jinjun Shi, Qingshan Yang and Xiuhua Liu and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Journal of Controlled Release.

In The Last Decade

Rongjun Qian

22 papers receiving 407 citations

Peers

Rongjun Qian

BIOMA

GENET

Zakia Belhadj China

Gülşah Erel‐Akbaba Türkiye

Heping Wang China

Thoudam Debraj Singh South Korea

Shuanglin Peng China

Wen Kuang China

Xumei Ouyang China

Sukyung Song South Korea

Samuel A. Jensen United States

Seok Ho Song South Korea

Zakia Belhadj China

Rongjun Qian

285 ×1.1

161 ×1.5

164 ×1.6

BIOMA

89 ×1.2

27 ×0.7

GENET

Citations per year, relative to Rongjun Qian Rongjun Qian (= 1×) peers Zakia Belhadj

Countries citing papers authored by Rongjun Qian

Since Specialization

Citations

This map shows the geographic impact of Rongjun Qian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongjun Qian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongjun Qian more than expected).

Fields of papers citing papers by Rongjun Qian

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongjun Qian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongjun Qian. The network helps show where Rongjun Qian may publish in the future.

Co-authorship network of co-authors of Rongjun Qian

This figure shows the co-authorship network connecting the top 25 collaborators of Rongjun Qian. A scholar is included among the top collaborators of Rongjun Qian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongjun Qian. Rongjun Qian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zhixiao, Rongjun Qian, Juntao Li, et al.. (2025). HERC5/ISG15 Enhances Glioblastoma Stemness and Tumor Progression by mediating SERBP1protein stability. NeuroMolecular Medicine. 27(1). 7–7. 1 indexed citations

Gao, Shanjun, Zhendong Liu, Hongbo Wang, et al.. (2023). Exploring the relationship between abnormally high expression of NUP205 and the clinicopathological characteristics, immune microenvironment, and prognostic value of lower-grade glioma. Frontiers in Oncology. 13. 1007198–1007198. 2 indexed citations

Liu, Zhendong, et al.. (2023). PSRC1 Regulated by DNA Methylation Is a Novel Target for LGG Immunotherapy. Journal of Molecular Neuroscience. 73(7-8). 516–528. 2 indexed citations

Cheng, Xingbo, et al.. (2023). ZNF480 influences the prognosis, pathogenesis, and immune microenvironment in patients with lower-grade glioma. Heliyon. 9(7). e18185–e18185. 3 indexed citations

Liu, Zhendong, et al.. (2022). Prognostic Significance of mRNA Expression RBBP8 or Its Methylation in Gliomas. Cellular and Molecular Neurobiology. 43(1). 409–422. 1 indexed citations

Cheng, Xingbo, Zhendong Liu, Xiang Sun, et al.. (2022). Cysteine cathepsin C: a novel potential biomarker for the diagnosis and prognosis of glioma. Cancer Cell International. 22(1). 53–53. 15 indexed citations

Cheng, Xingbo, Bo Pang, Sen Wang, et al.. (2022). Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma. International Immunopharmacology. 104. 108399–108399. 5 indexed citations

Liu, Zhendong, Binfeng Liu, Bo Zhang, et al.. (2022). High expression ofHOXA4in patients with glioma indicates unfavorable clinical outcomes. Cell Cycle. 21(22). 2387–2402. 5 indexed citations

Andrade-Barazarte, Hugo, et al.. (2022). Post-traumatic brain injury glioma: Characteristics, report of 2 cases report and literature review. Medicine. 101(52). e32477–e32477. 2 indexed citations

10.

Ruan, Weimin, Sen Xu, Muhammad Ismail, et al.. (2022). Brain-targeted CRISPR/Cas9 nanomedicine for effective glioblastoma therapy. Journal of Controlled Release. 351. 739–751. 53 indexed citations

11.

Zhang, Cheng, Rongjun Qian, Hongbo Wang, et al.. (2021). ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma. Frontiers in Oncology. 11. 608748–608748. 11 indexed citations

12.

Li, Yanxin, Ke Ma, Qi Xie, et al.. (2021). Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme. OncoTargets and Therapy. Volume 14. 5183–5195. 12 indexed citations

13.

Jiang, Tong, Weimin Ruan, Dongya Zhang, et al.. (2021). Cation‐Free siRNA Micelles as Effective Drug Delivery Platform and Potent RNAi Nanomedicines for Glioblastoma Therapy. Advanced Materials. 33(45). e2104779–e2104779. 100 indexed citations

14.

Wang, Xiqian, Liwei Peng, Juha Hernesniemi, et al.. (2020). Internal Jugular Vein Fenestration and Duplication: Anatomical Findings, Prevalence, and Literature Review. Frontiers in Surgery. 7. 593367–593367. 10 indexed citations

15.

Hanif, Sumaira, Pir Muhammad, Rose Chesworth, et al.. (2020). Nanomedicine-based immunotherapy for central nervous system disorders. Acta Pharmacologica Sinica. 41(7). 936–953. 47 indexed citations

16.

Qian, Rongjun, et al.. (2019). SiRNasome siRNAおよび薬物共デリバリーのためのカチオンを含まない多用途ナノ構造【JST・京大機械翻訳】. Angewandte Chemie International Edition. 131(15). 4992–4996. 1 indexed citations

17.

Zheng, Meng, Tong Jiang, Wen Yang, et al.. (2019). The siRNAsome: A Cation‐Free and Versatile Nanostructure for siRNA and Drug Co‐delivery. Angewandte Chemie. 131(15). 4992–4996. 20 indexed citations

18.

Li, Zhixiao, et al.. (2018). MiR-218-5p targets LHFPL3 to regulate proliferation, migration, and epithelial–mesenchymal transitions of human glioma cells. Bioscience Reports. 39(3). 24 indexed citations

19.

Qian, Rongjun, et al.. (2010). Expression of PirB in normal and injured spinal cord of rats. Journal of Huazhong University of Science and Technology [Medical Sciences]. 30(4). 482–485. 6 indexed citations

20.

Qian, Rongjun. (2009). Analysis of problems in seismic slice interpretation. 145–145. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact